Skip to main content

Table 2 Logistic regression analysis for the proposed predictors of liver decompensation

From: Role of residual liver volumetry and function in prediction of liver tolerability after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients: deriving a clinical decision support score

Predictor

Univariate analysis

B

SE

Wald

Sig.

OR (95% CI)

Demographic criteria

 • Age (years)

0.054

0.020

7.217

0.007

1.055 (1.015–1.097)

 • Sex (male)

− 0.001

0.284

0.000

0.996

0.999 (0.573–1.741)

Pre-intervention reserve liver functions

 • ALT (IU/L)

0.027

0.015

3.540

0.060

1.028 (0.999–1.057)

 • AST (IU/L)

0.025

0.013

3.573

0.059

1.025 (0.999–1.052)

 • s.albumin (gm/dl)

− 6.388

0.909

49.331

0.000

0.002 (0.000–0.010)

 • s.bilirubin (mg/dl)

3.122

0.694

20.254

0.000

22.692 (5.826–88.381)

 • PC (%)

− 0.178

0.036

23.891

0.000

0.837 (0.779–0.899)

Pre-interventional liver volumetric measures

 • Liver volume (LV) (cm3)

0.000

0.000

1.565

0.211

1.000 (1.000–1.001)

 • Tumor volume (TV) (cm3)

0.002

0.000

26.546

0.000

1.002 (1.001–1.0023)

 • Residual volume (RV) (cm3)

− 0.001

0.000

9.287

0.002

0.999 (0.998–0.999)

 • Residual to liver volumetric ratio (RLVR)

− 8.514

1.402

36.861

0.000

0.000 (0.000–0.003)

Other evaluated clinical and laboratory parameters

 • Spleen diameter (cm)

0.106

0.058

3.314

0.069

1.111 (0.992–1.245)

 • s.creatinine (mg/dl)

− 0.953

1.008

0.894

0.345

0.386 (0.054–2.780)

 • Platelets (× 103/mm3)

− 0.006

0.004

2.384

0.123

0.994 (90.987–1.002)

 • AFP (ng/ml)

0.001

0.001

3.592

0.058

1.001 (1.000–1.002)

 • Child-Pugh score

1.536

0.232

43.663

0.000

4.646 (2.946–7.358)